Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 23/01/26

Trade details

Type: Insider sale
Amount: $18,658.8
Shares · price: 852 sh · $21.90 a share
Held after: 32,871 sh
Stock: Travere Therapeutics TVTX
Person: Christopher R. ClineCFO
Trade date: 23/01/24
Filed: 23/01/26
Days to filing: 2 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/25~23/02/23

Christopher R. Cline's recent trades

Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$3.3M
50,508 sh
$3.3M
Filed 09/15
Traded 09/15
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05